索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]曹璐,李亚祺,石琳.中心动脉压监测在高血压中的应用[J].国际心血管病杂志,2024,01:49-52.
点击复制

中心动脉压监测在高血压中的应用(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2024年01期
页码:
49-52
栏目:
综述
出版日期:
2024-01-22

文章信息/Info

Title:
-
作者:
曹璐; 李亚祺; 石琳
100020 首都儿科研究所附属儿童医院心血管内科 北 京协和医学院研究生院（曹璐、石琳）；100020 北京，首都儿科 研究所附属儿童医院心血管内科（李亚祺）
Author(s):
-
关键词:
高血压; 中心动脉压; 无创性检测; 外周动脉压
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2024.01.014
文献标识码:
-
摘要:
监测血压是诊断高血压的金标准，目前临床上通过测量外周动脉压变化对高血 压患者进行管理。然而近年来，多项研究显示中心动脉压更能反映大动脉血压变化，监测中 心动脉压有助于高血压的预防与管理。该文介绍中心动脉压的产生和测量以及其在高血压 防治中的应用。
Abstract:
-

参考文献/References

[1] 马丽媛, 吴亚哲, 陈伟伟. 《中国心血管病报告2018》要点介 绍[J]. 中华高血压杂志, 2019, 27(8):712-716.
[2] Wang Z, Chen Z, Zhang L, et al. Status of hypertension in China: results from the China hypertension survey, 2012-2015[J]. Circulation, 2018, 137(22):2344-2356.
[3] Picone DS, Schultz MG, Otahal P, et al. Accuracy of cuffmeasured blood pressure: systematic reviews and metaanalyses[ J]. J Am Coll Cardiol, 2017, 70(5):572-586.
[4] Kollias A, Lagou S, Zeniodi ME, et al. Association of central versus brachial blood pressure with target-organ damage: systematic review and meta-analysis[J]. Hypertension, 2016, 67(1):183-190.
[5] Zuo J, Chang G, Tan I, et al. Central aortic pressure improves prediction of cardiovascular events compared to peripheral blood pressure in short-term follow-up of a hypertensive cohort[J]. Clin Exp Hypertens, 2020, 42(1):16-23.
[6] Cheng YB, Xia JH, Li Y, et al. Antihypertensive treatment and central arterial hemodynamics: a meta-analysis of randomized controlled trials[J]. Front Physiol, 2021, 12:762586.
[7] Townsend RR, Rosendorff C, Nichols WW, et al. American Society of Hypertension position paper: central blood pressure waveforms in health and disease[J]. J Am Soc Hypertens, 2016, 10(1):22-33.
[8] Avolio AP, Butlin M, Walsh A. Arterial blood pressure measurement and pulse wave analysis—their role in enhancing cardiovascular assessment[J]. Physiol Meas, 2010, 31(1):R1- R47.
[9] Echeverri D, Pizano A, Cabrales J, et al. Validation of central and peripheral non-invasive hemodynamic variables using an oscillometric method[J]. High Blood Press Cardiovasc Prev, 2018, 25(1):65-77.
[10] Gotzmann M, Hogeweg M, Seibert FS, et al. Accuracy of fully automated oscillometric central aortic blood pressure measurement techniques[J]. J Hypertens, 2020, 38(2):235-242.
[11] Mynard JP, Goldsmith G, Springall G, et al. Central aortic blood pressure estimation in children and adolescents: results of the KidCoreBP study[J]. J Hypertens, 2020, 38(5):821-828.
[12] Gotzmann M, Hogeweg M, Bauer F, et al. The impact of calibration approaches on the accuracy of oscillometric central aortic blood pressure measurement[J]. J Hypertens, 2020, 38(11):2154-2160.
[13] Protogerou AD, Blacher J, Safar ME. Isolated systolic hypertension: 'to treat or not to treat' and the role of central haemodynamics[J]. J Hypertens, 2013, 31(4):655-658.
[14] Lurbe E, Torro MI, Alvarez-Pitti J, et al. Central blood pressure and pulse wave amplification across the spectrum of peripheral blood pressure in overweight and obese youth[J]. J Hypertens, 2016, 34(7):1389-1395.
[15] McEniery CM, Yasmin, McDonnell B, et al. Central pressure: variability and impact of cardiovascular risk factors: the Anglo- Cardiff Collaborative Trial II[J]. Hypertension, 2008, 51(6):1476- 1482.
[16] Saladini F, Santonastaso M, Mos L, et al. Isolated systolic hypertension of young-to-middle-age individuals implies a relatively low risk of developing hypertension needing treatment when central blood pressure is low[J]. J Hypertens, 2011, 29(7):1311-1319.
[17] Hulsen HT, Nijdam ME, Bos WJ, et al. Spurious systolic hypertension in young adults; prevalence of high brachial systolic blood pressure and low central pressure and its determinants[J]. J Hypertens, 2006, 24(6):1027-1032.
[18] Obrycki ?, Feber J, Brzezińska G, et al. Evolution of isolated systolic hypertension with normal central blood pressure in adolescents-prospective study[J]. Pediatr Nephrol, 2021, 36(2):361-371.
[19] Vlachopoulos C, Aznaouridis K, O'Rourke MF, et al. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis[J]. Eur Heart J, 2010, 31(15):1865-1871.
[20] 肖文凯, 叶平, 白永怿, 等. 中心动脉脉压是影响大动脉僵硬度 的主要因素[J]. 南方医科大学学报, 2015, 35(1):34-39.
[21] Roman MJ, Devereux RB, Kizer JR, et al. High central pulse pressure is independently associated with adverse cardiovascular outcome the strong heart study[J]. J Am Coll Cardiol, 2009, 54(18):1730-1734.
[22] Roman MJ, Devereux RB, Kizer JR, et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study[J]. Hypertension, 2007, 50(1):197-203.
[23] Ghiadoni L, Bruno RM, Cartoni G, et al. Combination therapy with lercanidipine and enalapril reduced central blood pressure augmentation in hypertensive patients with metabolic syndrome[J]. Vascul Pharmacol, 2017, 92:16-21.
[24] Cui R, Li Y, Krisztina G, et al. An association between central aortic pressure and subclinical organ damage of the heart among a general Japanese cohort: Circulatory Risk in Communities Study (CIRCS)[J]. Atherosclerosis, 2014, 232(1):94-98.
[25] DeLoach SS, Daskalakis C, Gidding S, et al. Central blood pressures are associated with left ventricular mass index among African-American adolescents[J]. Am J Hypertens, 2012, 25(1):41-45.
[26] Litwin M, Obrycki ?, Niemirska A, et al. Central systolic blood pressure and central pulse pressure predict left ventricular hypertrophy in hypertensive children[J]. Pediatr Nephrol, 2019, 34(4):703-712.
[27] 钟萍, 张清琼, 郭建淑, 等. 老年高血压患者中心动脉压与肾功 能的相关性[J]. 中国老年学杂志, 2017, 37(14):3461-3463.
[28] Fujiwara T, Yano Y, Hoshide S, et al. Association between change in central nocturnal blood pressure and urine albumin-creatinine ratio by a valsartan/amlodipine combination: a CPET study[J]. Am J Hypertens, 2018, 31(9):995-1001.
[29] Williams B, Lacy PS, Thom SM, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study[J]. Circulation, 2006, 113(9):1213-1225.
[30] Boutouyrie P, Achouba A, Trunet P, et al. Amlodipine-valsartan combination decreases central systolic blood pressure more effectively than the amlodipine-atenolol combination: the EXPLOR study[J]. Hypertension, 2010, 55(6):1314-1322.
[31] Shimizu M, Hoshide S, Ishikawa J, et al. Correlation of central blood pressure to hypertensive target organ damages during antihypertensive treatment: the J-TOP study[J]. Am J Hypertens, 2015, 28(8):980-986.
[32] Pucci G, Ranalli MG, Battista F, et al. Effects of β-blockers with and without vasodilating properties on central blood pressure: systematic review and meta-analysis of randomized trials in hypertension[J]. Hypertension, 2016, 67(2):316-324.
[33] Kampus P, Serg M, Kals J, et al. Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness[J]. Hypertension, 2011, 57(6):1122-1128.
[34] Rimoldi SF, Messerli FH, Cerny D, et al. Selective heart rate reduction with ivabradine increases central blood pressure in stable coronary artery disease[J]. Hypertension, 2016, 67(6):1205-1210.
[35] Cheng HM, Chuang SY, Sung SH, et al. Derivation and validation of diagnostic thresholds for central blood pressure measurements based on long-term cardiovascular risks[J]. J Am Coll Cardiol, 2013, 62(19):1780-1787.

备注/Memo

备注/Memo:
基金项目：首都临床诊疗技术研究及转化应用项目 （Z211100002921035）；北京市医院管理中心儿科学科协同发展中心 儿科专项（XTYB201801）
通信作者：石琳， E-mail：shilin9789@126.com
更新日期/Last Update: 2024-01-22